Lifecycle of a Medical Device

The regulatory lifecycle of a medical device in Canada spans from initial concept through to eventual market withdrawal. Health Canada's requirements apply at multiple stages.

Stage 1 — Concept and design

During the concept and early design phase, key regulatory activities include:

• Determining if the product is a medical device — see What is a Medical Device?
• Classifying the device — determine the applicable class (I–IV) under Schedule 2 of the MDR — see How Classification Works
• Understanding the regulatory pathway — Device Licence vs. MDEL-only
• Engaging Health Canada early — for novel or complex devices, a Pre-Submission Meeting helps clarify requirements before significant investment

Stage 2 — Development and testing

During product development:

• Design controls (documented in the QMS per ISO 13485) must be applied
• Safety and effectiveness testing against Schedule 1 requirements and applicable recognised standards must be conducted
• For Class III and IV devices, clinical evidence must be generated or gathered
• Risk management per ISO 14971 must be conducted and documented
• For devices used in clinical investigations, an Investigational Testing Authorization (ITA) may be required

Stage 3 — Pre-market authorisation

Before the device can be sold in Canada:

• Class I devices: importer/distributor must hold an MDEL — no Device Licence needed
• Class II–IV devices: manufacturer must obtain a Device Licence from Health Canada
• The Device Licence application must include safety and effectiveness evidence, labelling (bilingual), standards compliance, and QMS documentation

Stage 4 — Market entry

Once licensed:

• The device is listed in the Medical Devices Active Licence Listing (MDALL) database
• Importers and distributors must hold a current MDEL
• Bilingual labelling (English and French) must be in place before placing the device on the Canadian market

Stage 5 — Post-market (ongoing)

After market entry, ongoing obligations include:

• Mandatory problem reporting — reporting device-related incidents within defined timeframes
• Post-market surveillance — systematic monitoring of device performance — see PMS Requirements
• Recalls — removing or correcting devices when a safety issue arises — see When a Recall is Required
• Licence amendments — notifying Health Canada of changes that affect safety, effectiveness, or labelling
• MDEL maintenance — keeping establishment licence information current
• Annual charges — paying annual fees to maintain the Device Licence

Stage 6 — Product changes

Throughout the product lifecycle, changes to the device may require:

• A Device Licence amendment for changes that affect safety, effectiveness, or labelling
• Updating the risk management file
• Re-validation of affected design elements

Stage 7 — Market withdrawal

When a device is withdrawn from the Canadian market:

• The manufacturer may request cancellation of the Device Licence
• Health Canada publishes the cancellation in the MDALL database
• Post-market obligations (including responding to outstanding incidents and completing any ongoing recalls) continue until all distributed devices are accounted for
• Distribution records must be retained for the required period after the last distribution